Refine by
Metabolic Disorder Services
12 services found
Manufactured by:Lupin Limited based inMumbai, INDIA
The NDDD team has developed a pipeline of highly differentiated and innovative new chemical entities in focused therapeutic areas of Oncology, Immunology and Metabolic ...
by:Cmbio based inCopenhagen, DENMARK
The gut microbiome is central to digestive health and metabolic processes, influencing conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and metabolic disorders like obesity and diabetes. At Cmbio, we offer multi-omics solutions to explore the connections between the gut microbiome, digestion, and ...
by:Azafaros based inNaarden, NETHERLANDS
Azafaros B.V. is pioneering the development of innovative oral small molecule compounds addressing the pathological effects of metabolite accumulation in rare metabolic disorders. Their lead compound, nizubaglustat, leverages unique dual-mode action, making it a promising candidate for modifying diseases irrespective of patient genotypes. Notably effective ...
by:Mithas Labs Clinical Trials Research Foundation Pvt., Ltd. based inChennai, INDIA
Mithas Labs' Doctor Panel’s expertise in virology, cancer markers, and molecular biology aiming to make our laboratories centre of excellence in therapeutic areas such as Infectious diseases, Oncology, Immunology and allergy, Molecular genetics and pharmacogenomics, Cardiovascular, Metabolism and diabetes, Gastric disorders, Antibiotic drugs, Generic drugs, ...
by:Vaiomer based inLabège, FRANCE
Bacterial translocation: the missing link between intestinal microbiome and human complex non-communicable diseases. Complex disorders are multifactorial and often chronic, caused by genetic and environmental factors and comprising hundreds of conditions from cardio-metabolic diseases to neurodegenerative and mental disorders. These pathologies ...
Manufactured by:Angionica Ltd. based inLodz, POLAND
The first test implemented by Angionica is the FMSF–PORH test (Flow Mediated Skin Fluorescence–Post-Occlusive Reactive Hyperemia), which is used to assess microvascular circulation (vascular endothelial function) based on circulatory stimulation in response to induced reactive hyperemia (PORH). The test makes it possible to assess levels of both contraction and vasodilation and to ...
by:SGS M-SCAN Ltd based inWokingham, UNITED KINGDOM
In collaboration with the clinical team, SGS has actively pursued innovative biomarker assay development and validation. To complement our range of immunoassays, we are now offering LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers such as steroidal and hormonal substances in the low picogram range. We have also invested in the field of multiplexing, using ...
by:Activation Laboratories Ltd. based inAncaster, ONTARIO (CANADA)
ActLabs Biotech scientists can assist with innovative biomarker assay development and validation. To compliment our range of immunoassays, we also offer LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers. In addition, we have invested in the field of multiplexing, using a bead-based suspension and electro-chemiluminescence-based platform ( Luminex Biorad ...
Manufactured by:Arthus Biosystems, LLC based inChantilly, VIRGINIA (USA)
SAM analog and antibody: One of the important S-adenosylmethionine (SAM) analogs has a very good thermostability and yet a high hygroscopicity. This analog can also be used as a standard in in intro assays of ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Short chain fatty acids (SCFAs) are a subgroup of saturated aliphatic fatty acids containing 2-5 carbon atoms, with acetate (C2), propionate (C3), and butyrate (C4) being the most abundant. They are the final products of dietary fiber fermented by beneficial coliform bacteria. Humans lack enzymes capable of degrading large amounts of dietary fiber, which passes undigested through the upper ...
by:ICON plc based inDublin, IRELAND
ICON has extensive experience in cardiovascular clinical research trials across the entire drug development spectrum. There is still significant unmet need within select cardiovascular/metabolic (CVM) disorders. Unfortunately, the cost of developing drugs and devices in this area has been rising steadily. ICON, a full service provider, takes a data-driven ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Metabolic bone disease encompasses a range of bone disorders caused by congenital or acquired factors that disrupt normal bone metabolism and biochemical states, leading to disorders in bone biochemistry and metabolism. These disorders stem from abnormalities in three key areas: bone resorption, ...